Human leukocyte antigen antibodies and chronic rejection: from association to causation
- PMID: 18698239
- DOI: 10.1097/TP.0b013e31817c4cb8
Human leukocyte antigen antibodies and chronic rejection: from association to causation
Abstract
Considerable research has established an association between human leukocyte antigen antibodies and chronic rejection. Two new major developments now provide evidence that this relationship is in fact causative. First, recent studies of serial serum samples of 346 kidney transplant patients from four transplant centers show that de novo antibodies, can be detected before rejection. Moreover, serial testing revealed that when antibodies were not present, 528 patient years of good function was demonstrable in 149 patients. Second, among 90 patients whose grafts chronically failed, 86% developed antibodies before failure. To assess the likelihood of a causal link, we applied the nine widely accepted Bradford Hill criteria and conclude that the evidence supports a causal connection between human leukocyte antigen antibodies and chronic rejection. The clinical implication is significant because we hope this review will stimulate centers to begin the one remaining task of showing that antibody removal will indeed prevent chronic failure.
Similar articles
-
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.Transplantation. 2009 Aug 27;88(4):568-74. doi: 10.1097/TP.0b013e3181b11b72. Transplantation. 2009. PMID: 19696641
-
Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.Chin Med J (Engl). 2009 Feb 20;122(4):420-6. Chin Med J (Engl). 2009. PMID: 19302748
-
Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.Clin Transpl. 2006:241-53. Clin Transpl. 2006. PMID: 18365382
-
Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.Cardiol Young. 2011 Dec;21 Suppl 2:124-32. doi: 10.1017/S1047951111001703. Cardiol Young. 2011. PMID: 22152539 Review.
-
Monitoring and treating posttransplant human leukocyte antigen antibodies.Hum Immunol. 2009 Aug;70(8):655-9. doi: 10.1016/j.humimm.2009.04.019. Epub 2009 Apr 15. Hum Immunol. 2009. PMID: 19375466 Review.
Cited by
-
Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg.Clin Exp Immunol. 2014 Aug;177(2):464-77. doi: 10.1111/cei.12307. Clin Exp Immunol. 2014. PMID: 24611451 Free PMC article.
-
Liver Histopathology in Late Protocol Biopsies after Pediatric Liver Transplantation.Children (Basel). 2021 Aug 1;8(8):671. doi: 10.3390/children8080671. Children (Basel). 2021. PMID: 34438562 Free PMC article.
-
STICI: Split-Transformer with integrated convolutions for genotype imputation.Nat Commun. 2025 Jan 31;16(1):1218. doi: 10.1038/s41467-025-56273-3. Nat Commun. 2025. PMID: 39890780 Free PMC article.
-
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.Am J Transplant. 2013 Jun;13(6):1541-8. doi: 10.1002/ajt.12212. Am J Transplant. 2013. PMID: 23721554 Free PMC article.
-
The clinical impact of humoral immunity in pediatric renal transplantation.J Am Soc Nephrol. 2013 Mar;24(4):655-64. doi: 10.1681/ASN.2012070663. Epub 2013 Feb 28. J Am Soc Nephrol. 2013. PMID: 23449533 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical